BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4073859)

  • 1. Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics.
    Fleishaker JC; McNamara PJ
    Antimicrob Agents Chemother; 1985 Sep; 28(3):369-74. PubMed ID: 4073859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age.
    Tsuji A; Terasaki T; Imaeda N; Nishide K; Nakashima E
    J Pharmacobiodyn; 1985 Mar; 8(3):167-74. PubMed ID: 4009409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):241-61. PubMed ID: 6438301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding].
    Brion N; Contrepois A; Carbon C
    Presse Med; 1983 Feb; 12(5):293-6. PubMed ID: 6220387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of beta-lactam antibiotics on bilirubin-albumin complex: comparison by three methods, total bilirubin, unbound bilirubin and erythrocyte-bound bilirubin.
    Gulian JM; Dalmasso C; Gonard V
    Chemotherapy; 1990; 36(2):91-7. PubMed ID: 2311445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of the interstitial space in humans.
    Levitt DG
    BMC Clin Pharmacol; 2003 Jul; 3():3. PubMed ID: 12890292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of beta-lactam antibiotics.
    Bergan T
    Scand J Infect Dis Suppl; 1984; 42():83-98. PubMed ID: 6597564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tissue penetration of antibiotics.
    Bergan T
    Rev Infect Dis; 1981; 3(1):45-66. PubMed ID: 7013000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
    Wise R; Gillett AP; Cadge B; Durham SR; Baker S
    J Infect Dis; 1980 Jul; 142(1):77-82. PubMed ID: 7400630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for evaluating the penetration of beta-lactam antibiotics into tissues.
    Wise R
    Rev Infect Dis; 1986; 8 Suppl 3():S325-32. PubMed ID: 3529325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model.
    Van Etta LL; Peterson LR; Fasching CE; Gerding DN
    J Infect Dis; 1982 Sep; 146(3):423-8. PubMed ID: 7108283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids.
    DeGuchi Y; Terasaki T; Yamada H; Tsuji A
    J Pharmacobiodyn; 1992 Feb; 15(2):79-89. PubMed ID: 1403606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antimicrobial pharmacokinetics and pharmacodynamics in surgical prophylaxis.
    Redington J; Ebert SC; Craig WA
    Rev Infect Dis; 1991; 13 Suppl 10():S790-9. PubMed ID: 1754787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
    Weidekamm E; Stoeckel K; Egger HJ; Ziegler WH
    Antimicrob Agents Chemother; 1984 Dec; 26(6):898-902. PubMed ID: 6395801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases.
    Dibdin GH; Assinder SJ; Nichols WW; Lambert PA
    J Antimicrob Chemother; 1996 Nov; 38(5):757-69. PubMed ID: 8961045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison study of the kinetics of ceftizoxime penetration into extravascular spaces with known surface area/volume ratio in vitro and in vivo in rabbits.
    Van Etta LL; Fasching CE; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):49-53. PubMed ID: 6299185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.
    Faed EM
    Eur J Clin Pharmacol; 1981; 21(1):77-81. PubMed ID: 7333350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.